Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 400% increase over the number of companies inspected in the previous year, when one company received one inspection.
Most of the companies inspected at the time were involved in the Biologics sector. The second most common type of company inspected period worked in the Food and Cosmetics sector.
All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Avflight Corporation | Food and Cosmetics | 07/16/2024 | No Action Indicated (NAI) |
BioLife Plasma Services LP | Biologics | 12/12/2024 | No Action Indicated (NAI) |
BioLife Plasma Services LP | Biologics | 12/10/2024 | No Action Indicated (NAI) |
LifeServe Blood Center | Biologics | 04/25/2024 | No Action Indicated (NAI) |
The American National Red Cross | Biologics | 06/13/2024 | No Action Indicated (NAI) |